136 related articles for article (PubMed ID: 34174217)
1. Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy.
Abe M; Ozaki Y; Takahashi H; Ishii M; Masunaga N; Ismail TF; Iimuro S; Fujita R; Iwata H; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Miyauchi K; Ogawa H; Daida H; Shimokawa H; Saito Y; Matsuzaki M; Akao M; Kimura T; Nagai R
Am Heart J; 2021 Oct; 240():89-100. PubMed ID: 34174217
[TBL] [Abstract][Full Text] [Related]
2. High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
Taguchi I; Iimuro S; Iwata H; Takashima H; Abe M; Amiya E; Ogawa T; Ozaki Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Miyauchi K; Yamazaki T; Ito H; Otsuji Y; Kimura K; Takahashi J; Hirayama A; Yokoi H; Kitagawa K; Urabe T; Okada Y; Terayama Y; Toyoda K; Nagao T; Matsumoto M; Ohashi Y; Kaneko T; Fujita R; Ohtsu H; Ogawa H; Daida H; Shimokawa H; Saito Y; Kimura T; Inoue T; Matsuzaki M; Nagai R
Circulation; 2018 May; 137(19):1997-2009. PubMed ID: 29735587
[TBL] [Abstract][Full Text] [Related]
3. High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.
Omote K; Yokota I; Nagai T; Sakuma I; Nakagawa Y; Kamiya K; Iwata H; Miyauchi K; Ozaki Y; Hibi K; Hiro T; Fukumoto Y; Mori H; Hokimoto S; Ohashi Y; Ohtsu H; Ogawa H; Daida H; Iimuro S; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R; Anzai T
J Atheroscler Thromb; 2022 Jan; 29(1):50-68. PubMed ID: 33431716
[TBL] [Abstract][Full Text] [Related]
4. Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) Trial.
Miyauchi K; Kimura T; Shimokawa H; Daida H; Iimuro S; Iwata H; Ozaki Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Ohashi Y; Ohtsu H; Saito Y; Matsuzaki M; Nagai R;
Int Heart J; 2018 Mar; 59(2):315-320. PubMed ID: 29503404
[TBL] [Abstract][Full Text] [Related]
5. Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study.
Kamiya K; Takei M; Nagai T; Miyoshi T; Ito H; Fukumoto Y; Obara H; Kakuma T; Sakuma I; Daida H; Iimuro S; Shimokawa H; Kimura T; Nagai R; Anzai T
J Atheroscler Thromb; 2024 Jan; 31(1):61-80. PubMed ID: 37574272
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
Hagiwara N; Kawada-Watanabe E; Koyanagi R; Arashi H; Yamaguchi J; Nakao K; Tobaru T; Tanaka H; Oka T; Endoh Y; Saito K; Uchida T; Matsui K; Ogawa H
Eur Heart J; 2017 Aug; 38(29):2264-2276. PubMed ID: 28430910
[TBL] [Abstract][Full Text] [Related]
7. Residual Coronary Risk Factors Associated With Long-Term Clinical Outcomes in Patients With Coronary Artery Disease Treated With High- vs. Low-Dose Statin Therapy - REAL-CAD Substudy.
Higuma T; Akashi YJ; Fukumoto Y; Obara H; Kakuma T; Asaumi Y; Yasuda S; Sakuma I; Daida H; Shimokawa H; Kimura T; Iimuro S; Nagai R
Circ J; 2024 May; 88(6):995-1003. PubMed ID: 37482412
[TBL] [Abstract][Full Text] [Related]
8. Plasma ANGPTL8 Levels and Risk for Secondary Cardiovascular Events in Japanese Patients With Stable Coronary Artery Disease Receiving Statin Therapy.
Morinaga J; Kashiwabara K; Torigoe D; Okadome Y; Aizawa K; Uemura K; Kurashima A; Matsunaga E; Fukami H; Horiguchi H; Sato M; Sugizaki T; Miyata K; Kadomatsu T; Mukoyama M; Miyauchi K; Hokimoto S; Fukumoto Y; Hiro T; Hibi K; Nakagawa Y; Sakuma I; Ozaki Y; Iwata H; Iimuro S; Daida H; Shimokawa H; Kimura T; Matsuzaki M; Saito Y; Matsuyama Y; Nagai R; Oike Y
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1549-1559. PubMed ID: 37259862
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
[TBL] [Abstract][Full Text] [Related]
10. Pitavastatin for lowering lipids.
Adams SP; Alaeiilkhchi N; Wright JM
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012735. PubMed ID: 32557581
[TBL] [Abstract][Full Text] [Related]
11. Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study).
Shepherd J; Breazna A; Deedwania PC; LaRosa JC; Wenger NK; Messig M; Wilson DJ;
Am J Cardiol; 2016 Apr; 117(8):1199-205. PubMed ID: 26940556
[TBL] [Abstract][Full Text] [Related]
12. Peripheral microvascular dysfunction predicts residual risk in coronary artery disease patients on statin therapy.
Matsue Y; Yoshida K; Nagahori W; Ohno M; Suzuki M; Matsumura A; Hashimoto Y; Yoshida M
Atherosclerosis; 2014 Jan; 232(1):186-90. PubMed ID: 24401235
[TBL] [Abstract][Full Text] [Related]
13. Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease - An Observation From the REAL-CAD Study.
Toyota T; Morimoto T; Iimuro S; Fujita R; Iwata H; Miyauchi K; Inoue T; Nakagawa Y; Nishihata Y; Daida H; Ozaki Y; Suwa S; Sakuma I; Furukawa Y; Shiomi H; Watanabe H; Yamaji K; Saito N; Natsuaki M; Ohashi Y; Matsuzaki M; Nagai R; Kimura T
Circ J; 2023 Jan; 87(2):360-367. PubMed ID: 36104250
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of Baseline High-Sensitivity C-Reactive Protein Level and Renal Function for Patients With Acute Coronary Syndrome Undergoing Aggressive Lipid-Lowering Therapy: A Subanalysis of HIJ-PROPER.
Kawada-Watanabe E; Yamaguchi J; Kanbayashi K; Sekiguchi H; Arashi H; Ogawa H; Hagiwara N
Am J Cardiol; 2018 Dec; 122(11):1817-1823. PubMed ID: 30270178
[TBL] [Abstract][Full Text] [Related]
15. Pitavastatin: clinical effects from the LIVES Study.
Teramoto T
Atheroscler Suppl; 2011 Nov; 12(3):285-8. PubMed ID: 22152283
[TBL] [Abstract][Full Text] [Related]
16. The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial.
Zhao SP; Yu BL; Peng DQ; Huo Y
Atherosclerosis; 2014 Apr; 233(2):707-712. PubMed ID: 24603217
[TBL] [Abstract][Full Text] [Related]
17. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
18. Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease.
Ishii J; Kashiwabara K; Ozaki Y; Takahashi H; Kitagawa F; Nishimura H; Ishii H; Iimuro S; Kawai H; Muramatsu T; Naruse H; Iwata H; Tanizawa-Motoyama S; Ito H; Watanabe E; Matsuyama Y; Fukumoto Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Hokimoto S; Miyauchi K; Ohtsu H; Izawa H; Ogawa H; Daida H; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R
J Atheroscler Thromb; 2022 Oct; 29(10):1458-1474. PubMed ID: 34880156
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial.
Ihm SH; Chung WB; Lee JM; Hwang BH; Yoo KD; Her SH; Song WH; Chae IH; Park TH; Kim JH; Jeon DW; Cho BR; Kang SH; Park SD; Lee JB; Woo JT; Lee BW; Han KA; Won KH; Kim HS; Yu JM; Chung CH; Kim HJ; Cho HC; Seung KB
Clin Ther; 2020 Oct; 42(10):2021-2035.e3. PubMed ID: 32891418
[TBL] [Abstract][Full Text] [Related]
20. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N
J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
